BamSEC and AlphaSense Join Forces
Learn More

Yarrow Bioscience Inc. – Material Contracts

NASDAQ: YARW    
Share price (8/7/26): $41.43    
Market cap (8/7/26): $116 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.8
from 8-K 10 pages 1. Positions. as COO, You Will Report to the Chief Executive Officer of the Company (“CEO”) and You Shall Have All Duties, Authorities, and Responsibilities Customarily Associated With the COO Position. This Is a Full-Time Employment Position. It Is Understood and Agreed That You Will Not Engage in Any Other Employment, Consulting or Other Business Activities (Whether Full-Time or Part-Time), Except as Expressly Authorized in Writing by the Company. 2. Compensation
12/34/56
EX-10.7
from 8-K 11 pages On Behalf of Yarrow Bioscience, Inc. (F/K/a VYNE Therapeutics, Inc.) (The “Company”), We Are Very Pleased to Offer You Continued Employment as the Chief Executive Officer of the Company (“CEO”) Pursuant to This Letter Agreement (The “Agreement”). This Agreement Will Amend and Restate the January 6, 2026 Letter Agreement Between You and the Company, Provided You Accept Such Offer as Indicated by Your Signature Below, to Be Effective as of July 27, 2026 (The “Effective Date”). 1. Positions
12/34/56
EX-10.6
from 8-K 16 pages Yarrow Bioscience, Inc. 2026 Employee Stock Purchase Plan
12/34/56
EX-10.5
from 8-K 20 pages Yarrow Bioscience, Inc. 2026 Stock Incentive Plan
12/34/56
EX-10.1
from 10-Q 16 pages Tyler Zeronda 33 Hall Rd Chatham Nj 07928 Re: Yarrow Bioscience, Inc. – Employment Offer 2)compensation
12/34/56
EX-10.15
from S-4 5 pages More Terms on Your Offer: Our Offer to You Is Contingent On: ● Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. ● Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.14
from S-4 6 pages ​ More Terms on Your Offer: Our Offer to You Is Contingent On: · Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. · Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.13
from S-4 16 pages More Terms on Your Offer: Our Offer to You Is Contingent On: ● Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. ● Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.11
from S-4 18 pages Rtw Investments, LP 40 10th Avenue, 7th Floor New York, Ny 10014 WWW.RTWFUNDS.com
12/34/56
EX-10.8
from S-4 15 pages Yarrow Bioscience, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.7
from S-4 13 pages Indemnification Agreement
12/34/56
EX-10.6
from S-4 70 pages Certain Confidential Information Contained in This Document, Marked by [***],Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That Registrant Treats as Private or Confidential Exclusive License Agreement by and Between Shanghai Scizeng Medical Technology Co., Ltd. as Licensor and Yarrow Bioscience, Inc. as Licensee and [***] ​ and ​ [***] ​ and ​ [***] ​ And
12/34/56
EX-10.13
from DRS 5 pages More Terms on Your Offer: Our Offer to You Is Contingent On: · Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. · Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.12
from DRS 5 pages More Terms on Your Offer: Our Offer to You Is Contingent On: · Execution of a Proprietary Information, Inventions and Non-Solicitation/Non-Competition Agreement (Attached Below) by You. · Satisfactory Completion of Your Background Check, Satisfactory Reference Checks, and Submission of Valid Proof of Your Identity and Your Legal Authorization to Work in the United States
12/34/56
EX-10.11
from DRS 17 pages Rebecca Frey VELA.BIO@OUTLOOK.com
12/34/56
EX-10.8
from DRS 13 pages Yarrow Bioscience, Inc. 2025 Equity Incentive Plan
12/34/56
EX-10.7
from DRS 13 pages Indemnification Agreement
12/34/56
EX-10.6
from DRS 69 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That Registrant Treats as Private or Confidential Exclusive License Agreement by and Between Shanghai Scizeng Medical Technology Co., Ltd. as Licensor and Yarrow Bioscience, Inc. as Licensee and [***] and [***] and [***] and [***] as Guarantor
12/34/56
EX-10.1
from 425 22 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56
EX-10.1
from 8-K 22 pages Amendment No. 1 to Agreement and Plan of Merger and Reorganization
12/34/56